Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H26O12 |
| Molecular Weight | 446.4025 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 9 / 9 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)C1=C(O[C@@H]2O[C@H](CO[C@@H]3OC[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)C=CC=C1
InChI
InChIKey=VHUNCYDAXJGCLO-AHMNSWSSSA-N
InChI=1S/C19H26O12/c1-27-17(26)8-4-2-3-5-10(8)30-19-16(25)14(23)13(22)11(31-19)7-29-18-15(24)12(21)9(20)6-28-18/h2-5,9,11-16,18-25H,6-7H2,1H3/t9-,11-,12+,13-,14+,15-,16-,18+,19-/m1/s1
| Molecular Formula | C19H26O12 |
| Molecular Weight | 446.4025 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 9 / 9 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/16375889Curator's Comment: Description was created using several sources including:
https://www.ncbi.nlm.nih.gov/pubmed/17329839|https://www.ncbi.nlm.nih.gov/pubmed/21830886
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16375889
Curator's Comment: Description was created using several sources including:
https://www.ncbi.nlm.nih.gov/pubmed/17329839|https://www.ncbi.nlm.nih.gov/pubmed/21830886
Monotropitoside (gaultherin) is a natural plant-extracted salicylate derivative that can be used as a natural aspirin substitute. Gaultherin is the major constituent of salicylate derivatives fraction (SDF) isolated from Gaultheria yunnanensis, medicinal plant widely used in Chinese traditional medicine for the treatments of rheumatoid arthritis, swellings, pain, trauma, chronic tracheitis, cold and vertigo. In animal studies gaultherin showed to be a potent inhibitor of pain and acute inflammation like non-steroidal anti-inflammatory drugs (NSAIDs). Gaultherin demonstrated analgesic and anti-inflammatory effects in rodents lacking gastric ulcerogenic effect compared to aspirin exhibiting the peripheral analgesic properties rather than central analgesic effects. The study of gaultherin metabolism in mice and rats indicated that gaultherin could be metabolically converted to salicylate, which produced the pharmacological effects, and provided effective concentrations for an extended period. In vitro metabolism experiments demonstrated that gaultherin was metabolized by beta-glycosidase produced by human intestinal bacteria and esterases in intestine, blood and liver successively to release salicylate. Gaultherin, has a similar chemical structure to aspirin which suggests that gaultherin or some active metabolites could inhibit cyclooxygenase activity.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Synthesis and anti-nociceptive and anti-inflammatory effects of gaultherin and its analogs. | 2011-09 |
|
| Analgesic and anti-inflammatory activities of a fraction rich in gaultherin isolated from Gaultheria yunnanensis (FRANCH.) REHDER. | 2007-03 |
|
| Gaultherin, a natural salicylate derivative from Gaultheria yunnanensis: towards a better non-steroidal anti-inflammatory drug. | 2006-01-13 |
|
| [The presence of monotropitoside in the bark of Ostryopsis davidiana Decaisne]. | 1953-05 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16375889
Gaultherin (200 mg/kg) significantly inhibited the abdominal contractions in the acetic acid-induced writhing test in mice.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:56:48 GMT 2025
by
admin
on
Mon Mar 31 22:56:48 GMT 2025
|
| Record UNII |
39519L80TD
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5315244
Created by
admin on Mon Mar 31 22:56:48 GMT 2025 , Edited by admin on Mon Mar 31 22:56:48 GMT 2025
|
PRIMARY | |||
|
39519L80TD
Created by
admin on Mon Mar 31 22:56:48 GMT 2025 , Edited by admin on Mon Mar 31 22:56:48 GMT 2025
|
PRIMARY | |||
|
DTXSID20878440
Created by
admin on Mon Mar 31 22:56:48 GMT 2025 , Edited by admin on Mon Mar 31 22:56:48 GMT 2025
|
PRIMARY | |||
|
m198
Created by
admin on Mon Mar 31 22:56:48 GMT 2025 , Edited by admin on Mon Mar 31 22:56:48 GMT 2025
|
PRIMARY | Merck Index | ||
|
490-67-5
Created by
admin on Mon Mar 31 22:56:48 GMT 2025 , Edited by admin on Mon Mar 31 22:56:48 GMT 2025
|
PRIMARY |